홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Nitrazepam

HCID 4506
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
146-22-5
표준 SMILES
O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1
InChIKey
KJONHKAYOJNZEC-UHFFFAOYSA-N
분자식
C15H11N3O3
평균 분자량
281.27 g/mol
단동위원소 질량
281.08004122

개요

Nitrazepam is a 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the treatment of epileptic spasms in infants (West's syndrome). It has a role as an anticonvulsant, a sedative, a drug metabolite, a GABA modulator and an antispasmodic drug. It is a 1,4-benzodiazepinone and a C-nitro compound.

이름 및 식별자

우선 이름
Nitrazepam
IUPAC
7-nitro-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one
영어명
Nitrazepam
분자식
C15H11N3O3
분자량
281.27

이름 및 동의어

nitrazepamBenzalin146-22-5MogadonRadedormApodormCalsminEunoctinNeozepamNeuchlonicNitradosSonebon
이름 더 보기
Ntz1,3-dihydro-7-nitro-5-phenyl-2h-4-benzodiazepin-2-onela1Nitrazepam (CRM)1,3-dihydro-7-nitro-5-phenyl-1,4-benzodiazepin-2-one7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-oneLA 1Eatan
HipsalImesonRemnosSuremSomitranSonnolinTrazeninUnisomnia

데이터베이스 식별자

CAS
146-22-5
PubChem CID
4506
DTXSID
DTXSID5023372
ChEMBL
CHEMBL13209
ChEBI
CHEBI:7581
UNII
9CLV70W7HS
EC Number
205-665-2

물성

구조 계산 물성

XLogP
2.2
극성 표면적
87.3 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
4
회전 가능 결합 수
1
무거운 원자 수
21
형식 전하
0
복잡도
452

실험 및 물리화학적 성질

Drugs · 6건

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Benzodiazepines

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP · 2건

2.25

2.06

Solubility · 2건

2.99e-02 g/L

>42.2 [ug/mL] (The mean of the results at pH 7.4)

Human Drugs · 2건

Breast Feeding; Lactation; Milk, Human; Hypnotics and Sedatives; Anti-Anxiety Agents; Benzodiazepines

Pharmaceuticals

Melting Point225 °C
Physical DescriptionSolid
Collision Cross Section · 2건

166.3 Ų [M+H]+ [CCS Type: DT; Method: single field calibrated]

163.6 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

물리화학적 성질

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 49 reports by companies from 3 notifications to the ECHA C&L Inventory.

유해성 정보

Regulatory Information · 2건

DEA schedule IV controlled substance

Nitrazepam: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

독성 정보

Treatment · 1건

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

화학 및 산업

약리 정보

ATC Code · 3건

N05CD02

N - Nervous system

QN - Nervous system

Pharmacodynamics · 1건

Nitrazepam is a type of benzodiazepine drug. It is a powerful hypnotic drug which possesses strong sedative, anxiolytic, amnestic, anticonvulsant, and skeletal muscle relaxant properties. Nitrazepam shortens the time required to fall asleep and lengthens the duration of sleep. It is also useful for the management of myoclonic seizures.

Mechanism of Action · 1건

Nitrazepam belongs to a group of medicines called benzodiazepines. This drug affects central benzodiazepine receptors, which are associated with inhibitory GABA (gamma amino butyric acid)receptors, leading to enhanced GABA binding activity. GABA is a major neurotransmitter in the brain, which causes somnolence, relaxation of muscles, a decrease in anxiety and general central nervous system depression. Nitrazepam has anticonvulsant properties that may be attributed to its ability to bind to voltage-dependent sodium channels. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.

Biological Half-Life15-38 hours (mean elimination half life 26 hours).
Metabolism/MetabolitesIt is long acting, is lipophilic and is metabolised hepatically via oxidative pathways. [Wikipedia] Half Life: 15-38 hours (mean elimination half life 26 hours).
MeSH Pharmacological Classification · 4건

Drugs used to prevent SEIZURES or reduce their severity.

Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety.

Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here.

Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here.

관련 반응

7건
반응 기록 만들기
HRID 135958 반응식
HRID 135958반응물로
HRID 214363 반응식
HRID 214363반응물로
HRID 697239 반응식
HRID 697239반응물로
HRID 865711 반응식
HRID 865711반응물로
HRID 1729599 반응식
HRID 1729599반응물로
HRID 1973059 반응식
HRID 1973059생성물로
HRID 2418314 반응식
HRID 2418314반응물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
Nikkaji
J2.956D
녹는점
223 · 223-227C
끓는 점
423.94 °C · 423.94°C (rough estimate)
밀도
1.2309 · 1.2309 (rough estimate)
굴절률
1.57 · 1.5700 (estimate)
인화점
2 ℃ · 2℃
저장 조건
-20 °C · Controlled Substance, -20°C Freezer
용해도
물에는 거의 녹지 않으며, 에탄올에는 약간 녹습니다(96%).
산도 계수 (pKa)
2.9 · pKa 2.90 ± 0.05;10.39±0.04(H2O,t =25,I=0.015(KCl))(Approximate)
수용성
3.93 mg/L · 3.93mg/L(25℃)
주요 응용
의약품(소분자)
InChI
1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)
InChIKey
KJONHKAYOJNZEC-UHFFFAOYSA-N
SMILES
[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1
NIST
Nitrazepam(146-22-5)
EPA
2 H-1,4-Benzodiazepin-2-one, · 2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-nitro-5-phenyl- (146-22-5)

화학적 성질

Pink Solid

Health Effects · 1건

They cause slurred speech, disorientation and "drunken" behavior. They are physically and psychologically addictive. May cause a potentially dangerous rash that may develop into Stevens Johnson syndrome, an extremely rare but potentially fatal skin disease.

Exposure RoutesBioavailability is 53-94% following oral administration.
Toxicity Summary · 1건

Nitrazepam belongs to a group of medicines called benzodiazepines. It acts on benzodiazepine receptors in the brain which are associated with the GABA receptors causing an enhanced binding of GABA (gamma amino butyric acid) to GABAA receptors. GABA is a major inhibitory neurotransmitter in the brain, involved in inducing sleepiness, muscular relaxation and control of anxiety and fits, and slows down the central nervous system. The anticonvulsant properties of nitrazepam and other benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation.

Signs and Symptoms · 1건

Nitrazepam is a drug which is very frequently involved in drug intoxication, including overdose. Nitrazepam overdose may result in stereotypical symptoms of benzodiazepine overdose including intoxication, impaired balance, slurred speech. In cases of severe overdose this may progress to a comatose state with the possibility of death.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 4건

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Nitrazepam

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

안전 데이터

wgk
3
rtecs
DF2450000
ridadr
3249
독성
LD50 orally in rats: 825 ±80 mg/kg (Randall)
risk_code
22-36-20/21/22-11
hazard_code
Xn,F
safety_code
36/37/39-36/37-16
포장분류
III
위험 등급
6.1(b)
기존화학 물질
KE-10723
Hazard Classifications
Acute Tox. 4 Oral
스토리지 클래스
11 - Combustible Solids
Absorption, Distribution and ExcretionBioavailability is 53-94% following oral administration.
Cellular LocationsMembrane

용도 및 제조

Uses · 2건

Use (kg; approx.) in Germany (2009): ?100

Used to treat short-term sleeping problems (insomnia), such as difficulty falling asleep, frequent awakenings during the night, and early-morning awakening.

Use ClassificationPharmaceuticals

응용 분야

용도Anticonvulsant; hypnotic. Controlled substance (depressant)

상·하류 제품 정보

상류 원료

2-클로로아세트아마이드클로로아세틸 클로라이드2-Amino-5-nitrobenzophenoneP-클로로아닐린헥사민염화벤조일질산글리신 에틸에스터 염화수소2-AminobenzophenoneAcetamide, 2-amino-N-(2-benzoyl-4-nitrophenyl)-1,3-디하이드로-5-페닐-1,4-벤조디아제핀-2-온N-(2-벤조일-4-니트로페닐)-2-클로로아세트아미드P-톨루엔설폰 산
추가 설명 · 1건

정의ChEBI: A 1,4-benzodiazepinone that is 1,3-dihydro-2H-1,4-benzodiazepin-2-one which is substituted at positions 5 and 7 by phenyl and nitro groups, respectively. It is used as a hypnotic for the short-term management of insomnia and for the trea ment of epileptic spasms in infants (West's syndrome).